Evidence map›Paper›PMID 32566690›Full record

ReviewJournal of immunology research2020

Use of Chlorogenic Acid against Diabetes Mellitus and Its Complications.

Yongwang Yan, Xu Zhou, Kangxiao Guo, Feng Zhou, Hongqi Yang

Abstract readReview
In one paragraph

Review in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Untargeted Metabolomic and Phytochemical Profiling ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Effects ofInternational journal of molecular sciences · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Exploration and Preliminary Investigation of WiledCurrent issues in molecular biology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Phytochemical Constituent of Devil Weed (Molecules (Basel, Switzerland) · 2025
    Article
  18. Review
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongwang YanCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China.
Xu ZhouDepartment of Gastroenterology, Changsha Hospital of Traditional Chinese Medicine, Changsha, China.
Kangxiao GuoPharmaceutical College, Changsha Health Vocational College, Changsha, China.
Feng ZhouPharmaceutical College, Changsha Health Vocational College, Changsha, China.
Hongqi YangCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China.ORCID https://orcid.org/0000-0002-5250-3326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlorogenic acid (CA) is a phenolic compound commonly found in human plant-based diets. CA is the main component of many traditional Chinese medicine preparations, and in recent years, it has been found to have hypoglycemic, hypolipidemic, anti-inflammatory, antioxidant, and other pharmacological properties. Specifically, CA relieves the effects of, and prevents, diabetes mellitus (DM). In addition, CA is also beneficial against complications arising from DM, such as diabetic nephropathy (DN), diabetic retinopathy (DR), and diabetic peripheral neuropathy (DPN). Herein, we review the use of CA in the prevention and treatment of DM and its complications, providing a background for further research and medical uses.

Indexed as

AnimalsAntioxidantsChlorogenic AcidDiabetes ComplicationsDiabetes MellitusGene Expression Regulation, EnzymologicGlucoseHumansHypoglycemic AgentsInsulinInsulin ResistanceLipid MetabolismMetabolic Networks and PathwaysOxidative StressAntioxidantsChlorogenic AcidGlucoseHypoglycemic AgentsInsulin

Identifiers

PMID32566690
PMCPMC7275206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.